{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:37:53Z","timestamp":1762270673288},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,10,1]],"date-time":"1986-10-01T00:00:00Z","timestamp":528508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatr Neurol Sci"],"published-print":{"date-parts":[[1986,10]]},"DOI":"10.1007\/bf00454016","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T17:44:04Z","timestamp":1100281444000},"page":"83-87","source":"Crossref","is-referenced-by-count":12,"title":["Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI"],"prefix":"10.1007","volume":"236","author":[{"given":"H. W.","family":"Moises","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Waldmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0191-8869(84)90076-X","volume":"5","author":"GE Barnes","year":"1984","unstructured":"Barnes GE (1984) A brief note on two often ignored principles that tend to attenuate the magnitude of correlations. Person Individ Differ 5:361?363","journal-title":"Person Individ Differ"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01249880","volume":"59","author":"W Birkmayer","year":"1984","unstructured":"Birkmayer W, Riederer P, Linauer W, Knoll J (1984) l-Deprenyl plus l-phenylalanine in the treatment of depression. J Neural Trans 59:81?87","journal-title":"J Neural Trans"},{"key":"CR3","unstructured":"Blaser P, Gehring A (1972) Ein programmierter Kurs zur deutschsprachigen Ausgabe des Minnesota Multiphasic Personality Inventory. In: Hathaway SR, McKinley JC (Hrsg). Hans Huber, Bern"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-1781(82)90020-8","volume":"6","author":"L Demisch","year":"1982","unstructured":"Demisch L, Georgi K, Patzke B, Demisch K, Bochnik HJ (1982) Correlation of Platelet MAO Activity With Introversion: A Study on a German Rural Population. Psychiat Res 6:303?311","journal-title":"Psychiat Res"},{"key":"CR5","volume-title":"Das Freiburger Personlichkeitsinventar","author":"J Fahrenberg","year":"1973","unstructured":"Fahrenberg J, Selg H, Hample R (1973) Das Freiburger Personlichkeitsinventar. Hogrefe, G\u00f6ttingen"},{"key":"CR6","first-page":"1586","volume":"18","author":"E Fischer","year":"1968","unstructured":"Fischer E, Heller B, Miro A (1968) ?-phenylethylamine in human urine. Arzneimittelforsch 18:1586","journal-title":"Arzneimittelforsch"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01928707","volume":"28","author":"E Fischer","year":"1972","unstructured":"Fischer E, Spatz H, Heller B, Reggiani H (1972) Phenylethylamine content of human urine and rat brain. Its alterations in pathogenic conditions and after drug administration. Experientia 28:307?308","journal-title":"Experientia"},{"key":"CR8","first-page":"161","volume":"7","author":"E Fischer","year":"1973","unstructured":"Fischer E, Spatz H, Fernandex Labriola R (1973) Quantitative gas chromatographic determination and infrared spectrographic determination of urinary phenylethylamine. Biol Psychiatry 7:161?165","journal-title":"Biol Psychiatry"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1600-0447.1981.tb00697.x","volume":"63","author":"WF Gattaz","year":"1981","unstructured":"Gattaz WF, Beckmann H (1981) Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individuals. Acta Psychiat Scand 63:479?485","journal-title":"Acta Psychiat Scand"},{"key":"CR10","volume-title":"The Minnesota Multiphasic Personality Inventory Manual","author":"SR Hathaway","year":"1951","unstructured":"Hathaway SR, McKinley JC (1951) The Minnesota Multiphasic Personality Inventory Manual. The Psychological Corporation, New York"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0165-1781(81)90082-2","volume":"3","author":"DV Jeste","year":"1981","unstructured":"Jeste DV, Doonagaji DR, Panjwani D, Datta M, Potkin SG, Karoum F, Thatte S, Shet AS, Apte JS, Wyatt RJ (1981) Cross-cultural study of biochemical abnormality in paranoid schizophrenia. Psychiat Res 3:341?352","journal-title":"Psychiat Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01249097","volume":"60","author":"J Lauber","year":"1984","unstructured":"Lauber J, Waldmeier PC (1984) Determination of 2-Phenylethylamine in Rat Brain After MAO Inhibitors, and in Human CSF and Urine Capillary GC and Chemical Ionization MS. J Neural Trans 60:247?264","journal-title":"J Neural Trans"},{"key":"CR13","first-page":"235","volume":"6","author":"AD Mosnaim","year":"1973","unstructured":"Mosnaim AD, Inwang EE, Sugerman JH, de Martini W, Sabelli HC (1973) Ultraviolet spectrometric determination of 2phenylethylamine in biological samples and its possible correlation with depression. Biol Psychiatry 6:235?257","journal-title":"Biol Psychiatry"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2466\/pr0.1973.32.3c.1131","volume":"32","author":"RJ McLaughlin","year":"1973","unstructured":"McLaughlin RJ, Harrison NW (1973) Extraversion, neuroticism and the volunteer subject. Psychol Rep 32:1131?1134","journal-title":"Psychol Rep"},{"key":"CR15","first-page":"171","volume-title":"Monoamine oxidase inhibitors. The state of the Art","author":"N Mendis","year":"1981","unstructured":"Mendis N, Pare CMB, Sandler M, Glover V, Stern G (1981) (?)Deprenyl in treatment of depression. In: Youdim MBH, Paykel ES (eds) Monoamine oxidase inhibitors. The state of the Art. Wiley, Chichester, pp 171?176"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.142.5.508","volume":"142","author":"J Mendlewicz","year":"1983","unstructured":"Mendlewicz J, Youdim MBH (1983) l-Deprenyl, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double-blind evaluation. Brit J Psychiatry 142:508?511","journal-title":"Brit J Psychiatry"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0033291700023229","volume":"7","author":"DL Murphy","year":"1977","unstructured":"Murphy DL, Belmaker RH, Buchsbaum MS, Nichols A, Costa JL, Wyatt RJ (1977) Biogenic amine-related enzymes and personality variations in normals. Psychol Med 7:149?157","journal-title":"Psychol Med"},{"key":"CR18","first-page":"113","volume-title":"Noncatecholic phenylethylamines. Part I. Phenylethylamines: biological mechanisms and clinical aspects","author":"SR Philips","year":"1978","unstructured":"Philips SR (1978) ?-Phenylethylamines: a metabolically and pharmacologically active amine. In: Mosnaim AD, Wolf ME (eds) Noncatecholic phenylethylamines. Part I. Phenylethylamines: biological mechanisms and clinical aspects. MDekker, New York, pp 113?138"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.504988","volume":"206","author":"SG Potkin","year":"1979","unstructured":"Potkin SG, Karoum F, Chwang LW, Cannon-Spoor HE, Philips I, Wyatt RJ (1979) Phenylethylamine in paranoid chronic schizophrenia. Science 206:470?471","journal-title":"Science"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.1979.01780070027003","volume":"36","author":"F Quitkin","year":"1979","unstructured":"Quitkin F, Rifkin A, Klein DF (1979) Monoamine oxidase inhibitors. A review of antidepressant effectiveness. Arch Gen Psychiatry 36:749?760","journal-title":"Arch Gen Psychiatry"},{"key":"CR21","first-page":"265","volume":"2","author":"GP Reynolds","year":"1979","unstructured":"Reynolds GP (1979) Phenylethylamine ? a role in mental illness? TINS 2:265?268","journal-title":"TINS"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.131.6.695","volume":"131","author":"HC Sabelli","year":"1974","unstructured":"Sabelli HC, and Mosnaim AD (1974) The Phenylethylamine Hypothesis of Affective Behavior. Am J Psychiatry 131:695?699","journal-title":"Am J Psychiatry"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(76)90156-2","volume":"1","author":"M Sandler","year":"1976","unstructured":"Sandler M, Reynolds GP (1976) Does phenylethylamine cause schizophrenia? Lancet 1:70?71","journal-title":"Lancet"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(78)92037-8","volume":"2","author":"M Sandler","year":"1978","unstructured":"Sandler M, Ruthven CRJ, Goodwin BL, Field H, Matthews R (1978) Phenylethylamine overproduction in aggressive psychopaths. Lancet 2:1269?1270","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1192\/bjp.128.4.354","volume":"128","author":"P Tyrer","year":"1976","unstructured":"Tyrer P (1976) Towards rational therapy with monoamine oxidase inhibitors. Br J Psychiatry 128:354?360","journal-title":"Br J Psychiatry"},{"key":"CR26","first-page":"15","volume-title":"Proceedings of the IInd Trace Amines Symposium","author":"PC Waldmeier","year":"1985","unstructured":"Waldmeier PC, Buchle AM, Lauber J (1985) Cerebral 2-phenylethylamine concentrations and turnover not influenced by various pharmacological treatments in rats. In: Bieck H, Boulton AA, Maitre L, Riederer P (eds) Proceedings of the IInd Trace Amines Symposium. Humana Press Inc, Clifton, New Jersey, pp 15?26"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-3623(83)90020-4","volume":"14","author":"ME Wolf","year":"1983","unstructured":"Wolf ME, Mosnaim AD (1983) Phenylethylamine in neuropsychiatric disorders. Gen Pharmac 14:385?390","journal-title":"Gen Pharmac"}],"container-title":["European Archives of Psychiatry and Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00454016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00454016\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00454016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T01:35:47Z","timestamp":1554341747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00454016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,10]]}},"alternative-id":["BF00454016"],"URL":"https:\/\/doi.org\/10.1007\/bf00454016","relation":{},"ISSN":["0175-758X","1433-8491"],"issn-type":[{"value":"0175-758X","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,10]]}}}